All In Biotech

Drug Trial Radar · NCT03675308

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy

A Phase 3, Randomized, Double-Blind, Study Comparing Risankizumab to Placebo in Subjects With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1)

Last checked: Nov 20, 2026Latest source record: Aug 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 964 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

964

Actual

Start

Mar 25, 2019

Primary completion

Oct 8, 2020

Study completion Sep 28, 2026

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Sep 18, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the safety and efficacy of risankizumab versus placebo in participants with moderately to severely active psoriatic arthritis (PsA).

Conditions

  • Psoriatic Arthritis

Interventions

  • PlaceboBiological

    Placebo for risankizumab administered by subcutaneous injection

  • RisankizumabBiological

    Risankizumab administered by subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With an American College of Rheumatology 20% (ACR20) Response at Week 24Time frame: Baseline and Week 24

Locations

256 sites in 39 countries. Site status is shown where the registry gives one.

  • Pinnacle Research Group /ID# 167955

    Anniston, Alabama

  • Sun Valley Arthritis Center Ltd. /ID# 200270

    Peoria, Arizona

  • AZ Arthritis and Rheumotology Research, PLLC /ID# 209873

    Phoenix, Arizona

  • Arizona Arthritis & Rheumatology Research, PLLC /ID# 209875

    Tucson, Arizona

  • Southern Arizona VA Health Care System /ID# 209247

    Tucson, Arizona

  • Arthritis and Rheumatism Associates /ID# 209882

    Jonesboro, Arkansas

  • Valerius Medical Group & Research Center /ID# 207428

    Los Alamitos, California

  • Rheumatology Center of San Diego /ID# 201642

    San Diego, California

  • Inland Rheum Clin Trials Inc. /ID# 201641

    Upland, California

  • Medvin Clinical Research /ID# 211127

    Whittier, California

  • New England Research Associates, LLC /ID# 207237

    Bridgeport, Connecticut

  • Danbury Clinical Research, LLC /ID# 209517

    Danbury, Connecticut

  • Arthritis & Osteoporosis Center /ID# 207236

    Hamden, Connecticut

  • Arthritis & Rheumatic Disease Specialties /ID# 210802

    Aventura, Florida

  • Rheumatology Associates of South Florida (RASF) - Clinical Research /ID# 211099

    Boca Raton, Florida

  • SIMED Health, LLC /ID# 207461

    Gainesville, Florida

  • Sweet Hope Research Specialty Inc /ID# 209393

    Hialeah, Florida

  • Jacksonville Center for Clinical Research /ID# 209876

    Jacksonville, Florida

  • Rheum Assoc of Central FL /ID# 201622

    Orlando, Florida

  • HMD Research LLC /ID# 208427

    Orlando, Florida

  • IRIS Research and Development, LLC /ID# 208955

    Plantation, Florida

  • ForCare Clinical Research /ID# 168034

    Tampa, Florida

  • Arthritis and Rheumatology /ID# 168046

    Atlanta, Georgia

  • Affinity Clinical Research /ID# 210816

    Oak Brook, Illinois

  • OrthoIllinois /ID# 205300

    Rockford, Illinois

  • Springfield Clinic /ID# 200244

    Springfield, Illinois

  • Klein and Associates MD /ID# 169483

    Hagerstown, Maryland

  • The Center for Rheumatology and Bone Research /ID# 168017

    Wheaton, Maryland

  • Clinical Pharmacology Study Gr /ID# 168019

    Worcester, Massachusetts

  • Advanced Rheumatology, PC /ID# 168042

    Lansing, Michigan

  • June DO, PC /ID# 208915

    Lansing, Michigan

  • St. Paul Rheumatology /ID# 208471

    Eagan, Minnesota

  • Logan Health Research /ID# 213707

    Kalispell, Montana

  • Physician Research Collaboration, LLC /ID# 208670

    Lincoln, Nebraska

  • Center for Rheumatology LLP /ID# 207313

    Albany, New York

  • NYU Langone Ambulatory Care Brooklyn Heights /ID# 207310

    Brooklyn, New York

  • Joint & Muscle Research Instit /ID# 208620

    Charlotte, North Carolina

  • Medication Management, LLC /ID# 211734

    Greensboro, North Carolina

  • Coastal Carolina Health Care /ID# 208619

    New Bern, North Carolina

  • Velocity Clinical Research /ID# 200452

    Blue Ash, Ohio

Showing 40 of 256 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.